BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21288829)

  • 1. Coxiella burnetii antigen-stimulated dendritic cells mediated protection against Coxiella burnetii in BALB/c mice.
    Wei Y; Wang X; Xiong X; Wen B
    J Infect Dis; 2011 Jan; 203(2):283-91. PubMed ID: 21288829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mice immunized with bone marrow-derived dendritic cells stimulated with recombinant Coxiella burnetii Com1 and Mip demonstrate enhanced bacterial clearance in association with a Th1 immune response.
    Xiong X; Meng Y; Wang X; Qi Y; Li J; Duan C; Wen B
    Vaccine; 2012 Nov; 30(48):6809-15. PubMed ID: 23000126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient activation of T cells by human monocyte-derived dendritic cells (HMDCs) pulsed with Coxiella burnetii outer membrane protein Com1 but not by HspB-pulsed HMDCs.
    Wang Y; Xiong X; Wu D; Wang X; Wen B
    BMC Immunol; 2011 Sep; 12():52. PubMed ID: 21888659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine Receptor 7 Is Essential for Coxiella burnetii Whole-Cell Vaccine-Induced Cellular Immunity but Dispensable for Vaccine-Mediated Protective Immunity.
    Chen C; van Schaik EJ; Gregory AE; Vigil A; Felgner PL; Hendrix LR; Faris R; Samuel JE
    J Infect Dis; 2019 Jul; 220(4):624-634. PubMed ID: 30938819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble antigens derived from
    Gregory AE; van Schaik EJ; Fratzke AP; Russell-Lodrigue KE; Farris CM; Samuel JE
    Cell Rep Med; 2021 Dec; 2(12):100461. PubMed ID: 35028605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Q fever: persistence of antigenic non-viable cell residues of Coxiella burnetii in the host--implications for post Q fever infection fatigue syndrome and other chronic sequelae.
    Marmion BP; Sukocheva O; Storm PA; Lockhart M; Turra M; Kok T; Ayres J; Routledge H; Graves S
    QJM; 2009 Oct; 102(10):673-84. PubMed ID: 19556396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spread and distribution of Coxiella burnetii in C57BL/6J (H-2b) and Balb/cJ (H-2d) mice after intraperitoneal infection.
    Baumgärtner W; Dettinger H; Schmeer N
    J Comp Pathol; 1993 Feb; 108(2):165-84. PubMed ID: 8473567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major Histocompatibility Complex Class II-Restricted, CD4
    Ledbetter L; Cherla R; Chambers C; Zhang Y; Mitchell WJ; Zhang G
    Infect Immun; 2020 Feb; 88(3):. PubMed ID: 31792078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both Major Histocompatibility Complex Class I (MHC-I) and MHC-II Molecules Are Required, while MHC-I Appears To Play a Critical Role in Host Defense against Primary Coxiella burnetii Infection.
    Buttrum L; Ledbetter L; Cherla R; Zhang Y; Mitchell WJ; Zhang G
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29311245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii.
    Shannon JG; Heinzen RA
    Immunol Res; 2009; 43(1-3):138-48. PubMed ID: 18813881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-mediated immunity to the obligate intracellular bacterial pathogen Coxiella burnetii is Fc receptor- and complement-independent.
    Shannon JG; Cockrell DC; Takahashi K; Stahl GL; Heinzen RA
    BMC Immunol; 2009 May; 10():26. PubMed ID: 19426498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Coxiella burnetii CD8+ T-Cell Epitopes and Delivery by Attenuated Listeria monocytogenes as a Vaccine Vector in a C57BL/6 Mouse Model.
    Xiong X; Jiao J; Gregory AE; Wang P; Bi Y; Wang X; Jiang Y; Wen B; Portnoy DA; Samuel JE; Chen C
    J Infect Dis; 2017 May; 215(10):1580-1589. PubMed ID: 27703037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formalin-inactivated Coxiella burnetii phase I vaccine-induced protection depends on B cells to produce protective IgM and IgG.
    Zhang G; Peng Y; Schoenlaub L; Elliott A; Mitchell W; Zhang Y
    Infect Immun; 2013 Jun; 81(6):2112-22. PubMed ID: 23545296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coxiella burnetii Lipopolysaccharide: What Do We Know?
    Abnave P; Muracciole X; Ghigo E
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29168790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of immunodominant scaffolds of Com1 and OmpH antigens of Coxiella burnetii.
    Jaydari A; Forouharmehr A; Nazifi N
    Microb Pathog; 2019 Jan; 126():298-309. PubMed ID: 30447420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein array of Coxiella burnetii probed with Q fever sera.
    Wang X; Xiong X; Graves S; Stenos J; Wen B
    Sci China Life Sci; 2013 May; 56(5):453-9. PubMed ID: 23633077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CD4+ and CD8+ T cells in clearance of primary pulmonary infection with Coxiella burnetii.
    Read AJ; Erickson S; Harmsen AG
    Infect Immun; 2010 Jul; 78(7):3019-26. PubMed ID: 20351144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuated Coxiella burnetii phase II causes a febrile response in gamma interferon knockout and Toll-like receptor 2 knockout mice and protects against reinfection.
    Ochoa-Repáraz J; Sentissi J; Trunkle T; Riccardi C; Pascual DW
    Infect Immun; 2007 Dec; 75(12):5845-58. PubMed ID: 17893129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced protection against Q fever in BALB/c mice elicited by immunization of chloroform-methanol residue of Coxiella burnetii via intratracheal inoculation.
    Feng J; Hu X; Fu M; Dai L; Yu Y; Luo W; Zhao Z; Lu Z; Du Z; Zhou D; Wen B; Jiao J; Xiong X
    Vaccine; 2019 Sep; 37(41):6076-6084. PubMed ID: 31477436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promiscuous
    Scholzen A; Richard G; Moise L; Baeten LA; Reeves PM; Martin WD; Brauns TA; Boyle CM; Raju Paul S; Bucala R; Bowen RA; Garritsen A; De Groot AS; Sluder AE; Poznansky MC
    Front Immunol; 2019; 10():207. PubMed ID: 30828331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.